Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guides
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Shares
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
Europe midday: Shares rise on data; Mpox drug maker Bavarian Nordic surges
(Sharecast News) - European shares were higher as data from the US allayed fears of a potential recission, while upbeat retail sales figures in the UK also boosted sentiment. The pan-regional Stoxx 600 index was up 0.27% at 511.80, rounding off a more positive week for equities after the recent sell-off.
US markets all closed sharply higher overnight as unemployment claims in the US dipped unexpectedly during the previous week. According to the Department of Labor, in seasonally adjusted terms first time jobless claims fell by 7,000 over the week ending on 10 August to reach 227,000. Economists had forecast a slight rise to 235,000.
Retail sales in the world's biggest economy also jumped last month, driven by a rebound in auto purchases. According to the Department of Commerce, in seasonally adjusted terms, retail sales volumes shot 1.0% higher month-on-month to reach $709.7bn. That followed a revised 0.2% decline in June, but was more than twice the 0.3% gain projected by economists.
In the UK, retail sales rebounded to 0.5% growth in July from a 0.9% decline in the previous month, in line with expectations.
On the equities front, shares in Nibe were up as the Swedish heat pump maker reported first-half earnings.
Shares in Bavarian Nordic, which makes the Imvanex mpox vaccine surged by 16% as the first case of a more dangerous variant of the disease was reported in Asia.
The drugmaker on Friday said it was seeking approval from the European Union regulator for the jab - currently licensed only for adults - to be given to children aged 12 to 17.
Shares in German chemicals maker Bayer also jumped after a US appeals court said it was protected under federal law which would limit liability from claims that its Roundup weed killer causes cancer.
The case was brought by David Schaffner, a Pennsylvania landscaper diagnosed with non-Hodgkins lymphoma in 2006, who claimed the Bayer had failed to provide a cancer warning on the label of Roundup.
However, the US Circuit Court of Appeals in Philadelphia ruled that the Federal Insecticide, Fungicide, and Rodenticide Act required nationwide uniformity in pesticide labels, and stopped Pennsylvania from adding a cancer warning.
Shares in video game maker Embracer Group rallied a day after the company reported a sharp fall in first-quarter sales.
Reporting by Frank Prenesti for Sharecast.com
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.